Clinical Trial: Intralipid for Recurrent Miscarriage

Study Status: Recruiting
Recruit Status: Unknown status
Study Type: Interventional

Official Title: The Role of Intralipid in Natural Killer Cell Positive Cases With Recurrent Miscarriages Undergoing IVF/ICSI Cycles: a Double Blind Randomized Controlled Trial

Brief Summary: Intralipid infusion can improve the outcome in NK cells positive females with history of recurrent miscarriages undergoing IVF/ICSI cycles.

Detailed Summary:
Sponsor: Woman's Health University Hospital, Egypt

Current Primary Outcome: chemical pregnancy rate [ Time Frame: 10 months ]

Positive pregnancy test in blood as measured by quantitative B- hCG level


Original Primary Outcome: Same as current

Current Secondary Outcome: clinical pregnancy rate, [ Time Frame: 10 months ]

Confirmed pregnancy at 7 weeks by ultrasound visualization of gestational sac and positive fetal pulsations


Original Secondary Outcome: Same as current

Information By: Woman's Health University Hospital, Egypt

Dates:
Date Received: February 7, 2013
Date Started: February 2013
Date Completion: September 2015
Last Updated: May 31, 2015
Last Verified: May 2015